Next Article in Journal
Prevalence of Human Coronaviruses in Children and Phylogenetic Analysis of HCoV-OC43 during 2016–2022 in Riyadh, Saudi Arabia
Next Article in Special Issue
Determinants of Retroviral Integration and Implications for Gene Therapeutic MLV—Based Vectors and for a Cure for HIV-1 Infection
Previous Article in Journal
Surrogate Selection for Foot-and-Mouth Disease Virus in Disinfectant Efficacy Tests by Simultaneous Comparison of Bacteriophage MS2 and Bovine Enterovirus Type 1
Previous Article in Special Issue
Trajectories of CD4+/CD8+ T-Cells Ratio 96 Weeks after Switching to Dolutegravir-Based Two-Drug Regimens: Results from a Multicenter Prospective Cohort Study
 
 
Review
Peer-Review Record

Different Pathways Conferring Integrase Strand-Transfer Inhibitors Resistance

Viruses 2022, 14(12), 2591; https://doi.org/10.3390/v14122591
by Clémence Richetta *, Nhat Quang Tu and Olivier Delelis *
Reviewer 1:
Reviewer 2:
Reviewer 3: Anonymous
Viruses 2022, 14(12), 2591; https://doi.org/10.3390/v14122591
Submission received: 25 October 2022 / Revised: 17 November 2022 / Accepted: 19 November 2022 / Published: 22 November 2022
(This article belongs to the Special Issue Integrase Inhibitors 2023)

Round 1

Reviewer 1 Report

Excellent and very complete review on INSTIs. Very well written. Nice figures and well explained issues on resistance with these specific category of compounds.

I would add integrase also in the title of the review. Also "and al" I would do everywhere "and al." for refering to other authors.

 

 

Author Response

"Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

 

1.    How relevant is the circular unintegrated DNA in development of drug resistance, in other words what is the reported incidence of this mechanism of resistance development in clinical trials

2.    It is helpful to the reader to include a diagram that illustrates the basic integration process of the virus as described in the text.

3.    Please insert a reference for figures 1-2 if derived from a reference, otherwise if created by authors please reference the software used to create the chemical structures.

4.    Please consider explaining figure 4 further to make it easy for the reader to interpret without reading the text

5.     “One hypothesis can be advanced to explain this observation and is based on the half-life of the inhibitor on the intasome” it is also advisable to include a diagram to explain the proposed hypothesis

Author Response

Please see the attachment

Author Response File: Author Response.pdf

Reviewer 3 Report

The manuscript of Different pathways conferring strand-transfer inhibitors resistanceby Richetta et al. is well written, and can be published in Viruses. Some minor issues:

1. There are crystal structures available for HIV-1 integrase complexed with dolutegravir or other INSTIs in the PDB, therefore, Figure 2 can be modified to a 3D figure which can be gotten from the crystal structures.

2. More figures or tables which summary the information of the manuscript are needed to make this manuscript more readable.

3. IC50 in line 163, the 50 should be superscript.

Author Response

Please see the attachment

Author Response File: Author Response.pdf

Back to TopTop